Latest news
Trump's 2028 Generic Drug Tariff Plan Signals New Phase in U.S. Pharmaceutical Onshoring Push - Energy Earnings Report - dars.gov.etdars.gov.et · Mon, 03 Aug 2026 06:07:46 GMTTrump Plans Generic Drug Tariffs From 2028 With Two-Year Delay, Testing U.S. Onshoring Push - CFO Commentary Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:12:25 GMTTrump's Generic Drug Tariff Plan Set for 2028, Testing U.S. Onshoring Push - Tech Earnings Analysis - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:06:48 GMTTrump's 2028 Generic Drug Tariff Plan Tests U.S. Onshoring Push Against India's Supply Grip - Debt Analysis Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 09:17:01 GMTTrump's 2028 Generic Drug Tariff Plan Tests U.S. Onshoring Push Against India's Supply Grip - Positive Surprise Momentum - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 09:17:01 GMTTrump's 2028 Generic Drug Tariffs: Two-Year Delay Challenges U.S. Onshoring Push - Diluted EPS Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 03:46:20 GMTTrump's Proposed 2028 Generic Drug Tariffs Signal Two-Year Window for U.S. Onshoring Push - EBITDA Estimate Trend - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 02:01:51 GMTTrump Plans Generic Drug Tariffs for 2028 as Two-Year Delay Tests U.S. Onshoring Push - Return On Capital - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 18:01:49 GMT